/AOTI.L

AOTI.L Stock - AOTI, Inc.

Q: What is the analyst price target for AOTI.L?

Analyst price target information is not currently available for AOTI.L.

Q: What is AOTI.L's market cap?

Market capitalization information is not currently available for AOTI.L.

Healthcare|Medical - Specialties|LSE

$31.50+8.62%

+$2.50 (+8.62%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $34.65

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AOTI.L

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.08

52W High$125.00

52W Low$25.50

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	$58.36M	$43.92M	$8.86M	$889,098
Gross Profit	$51.35M	$37.59M	$2.86M	$45,359
Gross Margin	88.0%	85.6%	32.3%	5.1%
Operating Income	$1.25M	$-5,536,615	$2.29M	$-78,310
Net Income	$-1,756,000	$-8,187,210	$1.74M	$-86,819
Net Margin	-3.0%	-18.6%	19.7%	-9.8%
EPS	$-0.02	$-0.00	$-0.03	$0.02

Company Overview

AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.

Visit Website

Earnings History & Surprises

AOTI.L

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.04

Q3 2024

EPS Surprise History

Q2 23

No data

Q2 24

No data

Q3 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2025	Sep 22, 2025	—	—	—	—
Q2 2025	Apr 28, 2025	—	—	—	—
Q3 2024	Sep 16, 2024	—	$-0.04	—	—
Q2 2024	Jun 30, 2024	—	$-0.00	—	—
Q2 2023	Jun 30, 2023	—	$-0.00	—	—